Path AI / coverage

About

AI is all the hype, and that’s not always a good thing. SVM steers clients toward real thought leadership, not buzz.

For PathAI, SVM earned a March 2024 Health Data Management feature, “How Using AI in Pathology Can Aid Healthcare Equity and Efficiency,” featuring three PathAI executives, Eric Walk, MD, is Chief Medical Officer, Ben Glass is VP of AI Product & Translational Research, and Tafadzwa Muguwe, MD, is Sr. Director of Biopharma Operations. They discuss pathology’s role in diagnosing, treating, and monitoring disease, and how digital pathology and AI can improve patient outcomes, the physician experience, and the economics of care.

The piece positions PathAI’s leaders as practical voices in a market crowded with AI claims.